BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2013
View Archived Issues
Final results presented for glioblastoma multiforme trial of Cotara
Read More
Results from ongoing VAL-083 brain cancer trial
Read More
DS-5272 as a novel Hdm2 inhibitor for the treatment of relapsed and/or refractory MM
Read More
Otlertuzumab combined with rituximab shows promise in lymphocytic leukemia
Read More
Avanir releases results from phase II PRIME study
Read More
Ono and Receptos expand collaboration with GPCR technology platform transfer
Read More
Myriad Genetics forms research collaboration with Janssen Research & Development
Read More
Johnson & Johnson collaborates with Canadian early-stage drug technology centers
Read More
KU Leuven and Biocartis to develop diagnostic test for MMR-deficient cancer
Read More
CytRx reports data from global phase IIb trial of aldoxorubicin
Read More
Ario Pharma founded to develop therapies for respiratory indications
Read More
Novel fusion protein provides hope for hemophilia sufferers
Read More
to-BBB and Sihuan Pharmaceutical collaborate on treatments for CNS diseases
Read More
Abstral launched in Japan
Read More
MER-TIK, a novel tyrosine-protein kinase Mer inhibitor demonstrating antileukemic activity
Read More
C4 Imaging receives FDA 510(k) clearance for Sirius
Read More
E.U. funding for iHIVARNA program of HIV therapeutic vaccine
Read More
Bayer Schering Pharma patents novel sGC activators for cardiovascular disorders
Read More
Researchers at Bayer Schering Pharma present novel Mnk1 inhibitors
Read More
Venantius discloses new agents for IBD
Read More
Novel compounds for influenza prepared by European researchers
Read More
Ono Pharmaceutical synthesizes novel coagulation factor XIa inhibitors
Read More
Agents for HCV infection disclosed by Janssen R&D Ireland
Read More
Roche and Prothena collaborate on antibodies for Parkinson's disease
Read More
FDA committee recommends approval of metreleptin for generalized lipodystrophy
Read More
AstraZeneca presents novel FGFR-4 inhibitor with promising activity against HCC
Read More
Medivir begins phase IIa study combining simeprevir, TMC-647055 and JNJ-56914845
Read More
Agios Pharmaceuticals extends cancer metabolism collaboration with Celgene
Read More
